THURSDAY
Drugs Made In America Acquisition Corp. - Rights
SCoRE: 40
LAST PRICE - AT THE CLOSE
DMAAR is DOWN -68% since the begininning of the year
DMAAR is UP 10% ABOVE 20 day SMA
DMAAR is DOWN -61% BELOW 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 75.3% AWAY FROM ALL-TIME HIGHS OF $0.2433 |
 |
DMAAR IS DOWN -68% SINCE THE BEGINNING OF THE YEAR |
 |
DMAAR IS DOWN -57% OVER THE PAST 12 MONTHS |
 |
DMAAR IS DOWN -25% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL DMAAR INVESTORS ARE BETTING AGAINST DMAAR |
 |
NUM INVESTORS SHORT DMAAR HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | Trading 10% above VW... | 04/02 |
 | Trading 1% below VWA... | 04/02 |
 |
DMAAR moved up 0 in the previous minute |
 |
DMAAR is up 0 over the last hour |
 |
DMAAR is up 37.9% over the last 5 days |
 |
DMAAR is 16.1 above its 8 day SMA |
| $0.05 |   DAY |
$0.06 |
| $0.05 | PREVIOUS DAY |
$0.06 |
| $0.04 |  WEEK |
$0.10 |
| $0.04 | MONTH |
$0.10 |
| $0.04 | YEAR |
$0.24 |
DMAAR is mentioned N/A less than normal on 
DMAAR is mentioned N/A times in an average day on 
